Related Experiment Video
Updated: Apr 1, 2026
08:40
Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
10.9K
Secreted Ephrin Receptor A7 Promotes Somatic Cell Reprogramming by Inducing ERK Activity Reduction
Joonseong Lee1, May Nakajima-Koyama2, Masamitsu Sone3
1Department of Cell and Developmental Biology, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan.
Stem Cell Reports
|October 7, 2015
Summary
Secreted truncated ephrin receptor A7 (EPHA7) is a key regulator of cellular reprogramming. It restores reprogramming efficiency by reducing ERK activity during the middle phase.
Area of Science:
- Cellular reprogramming
- Molecular biology
- Signal transduction
Background:
- The role of secreted molecules in cellular reprogramming remains largely unknown.
- Identifying novel regulators is crucial for understanding and enhancing reprogramming processes.
Purpose of the Study:
- To identify key secreted molecules involved in cellular reprogramming.
- To elucidate the mechanism by which these molecules regulate reprogramming efficiency.
Main Methods:
- Investigated the role of ephrin receptor A7 (EPHA7) in cellular reprogramming.
- Utilized gene knockdown and addition of truncated EPHA7 to assess its function.
- Analyzed extracellular signal-regulated kinase (ERK) pathway activity during reprogramming.
Main Results:
- Truncated EPHA7 is upregulated and secreted during reprogramming, regulated by OCT3/4.
- EphA7 knockdown significantly reduces reprogramming efficiency.
- Secreted truncated EPHA7 restores reprogramming efficiency by reducing ERK activity.
- ERK pathway inhibition rescues reprogramming in EphA7-knockdown cells.
Conclusions:
- Secreted truncated EPHA7 is a critical regulator of cellular reprogramming.
- Reduced ERK activity mediated by truncated EPHA7 is essential for reprogramming progression.
- These findings reveal a novel mechanism involving secreted EPHA7 in cellular reprogramming.
Related Concept Videos
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.8K
01:29Somatic to iPS Cell Reprogramming
2.9K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
01:24Methods of Nuclear Reprogramming
2.3K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.3K
02:38Mitogens and the Cell Cycle
8.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
01:32Chromatin Modification in iPS Cells
2.3K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K
01:15Receptor Downregulation in MVBs
3.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
3.0K